The effect of altruism on COVID-19 vaccination rates
After the emergence of the first vaccines against the COVID-19, public health authorities have promoted mass vaccination in order to achieve herd immunity and reduce the effects of the disease. Vaccination rat... (Source: Health Economics Review)
Source: Health Economics Review - January 3, 2023 Category: Health Management Authors: Luis Á. Hierro, David Patiño, Pedro Atienza, Antonio J. Garzón and David Cantarero Tags: Research Source Type: research
Transcatheter aortic valve implantation against conventional aortic valve replacement surgery in high-risk patients with aortic stenosis; a cost-effectiveness analysis
ConclusionsTAVI does not seem a cost-effective procedure in comparison with SAVR at the current willingness to pay thresholds of the country. However, by increasing the WTP threshold to 3 times the GDP per capita the probability of being cost-effective will raise to 83%. (Source: Health Economics Review)
Source: Health Economics Review - January 3, 2023 Category: International Medicine & Public Health Source Type: research
The effect of altruism on COVID-19 vaccination rates
ConclusionsAltruism is a useful tool to define future vaccination strategies, since it favors the individuals ’ awareness for vaccination. (Source: Health Economics Review)
Source: Health Economics Review - January 3, 2023 Category: International Medicine & Public Health Source Type: research
Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non –small cell lung cancer in China
ConclusionCompared with chemotherapy alone, the sintilimab plus chemotherapy is likely to be a cost-effective option as the first-line treatment for locally advanced or metastatic nonsquamous NSCLC in China. (Source: Health Economics Review)
Source: Health Economics Review - December 30, 2022 Category: International Medicine & Public Health Source Type: research
Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non –small cell lung cancer in China
In frst-line treatment of advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC), the ORIENT-11 study demonstrated a signifcant progression-free survival and overall survival for sintilimab plus... (Source: Health Economics Review)
Source: Health Economics Review - December 30, 2022 Category: Health Management Authors: Huiqin Liu, Ying Wang and Qi He Tags: Research Source Type: research
Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non –small cell lung cancer in China
ConclusionCompared with chemotherapy alone, the sintilimab plus chemotherapy is likely to be a cost-effective option as the first-line treatment for locally advanced or metastatic nonsquamous NSCLC in China. (Source: Health Economics Review)
Source: Health Economics Review - December 30, 2022 Category: International Medicine & Public Health Source Type: research
A decision support tool with health economic modelling for better management of DVT patients
ConclusionsThe combination of DES and STAR can help decision-makers determine the interventions that have the highest benefits from service providers' and patients ’ perspectives. This is important given the mismatch between care demand and resources and the resulting need for improving operational and economic outcomes. The DST tool has the potential to inform policymaking in DVT services in the UK to improve performance. (Source: Health Economics Review)
Source: Health Economics Review - December 26, 2022 Category: International Medicine & Public Health Source Type: research
A decision support tool with health economic modelling for better management of DVT patients
Responding to the increasing demand for Deep Vein Thrombosis (DVT) treatment in the United Kingdom (UK) at times of limited budgets and resources is a great challenge for decision-makers. Therefore, there is a... (Source: Health Economics Review)
Source: Health Economics Review - December 26, 2022 Category: Health Management Authors: Reda Lebcir, Usame Yakutcan and Eren Demir Tags: Research Source Type: research
A decision support tool with health economic modelling for better management of DVT patients
ConclusionsThe combination of DES and STAR can help decision-makers determine the interventions that have the highest benefits from service providers' and patients ’ perspectives. This is important given the mismatch between care demand and resources and the resulting need for improving operational and economic outcomes. The DST tool has the potential to inform policymaking in DVT services in the UK to improve performance. (Source: Health Economics Review)
Source: Health Economics Review - December 26, 2022 Category: International Medicine & Public Health Source Type: research
Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan
ConclusionsWe clarified the health state utility values of patients with metastatic pancreatic cancer based on the general population in Japan. The effect on utilities should be considered not only for serious AEs, but also for minor AEs. (Source: Health Economics Review)
Source: Health Economics Review - December 24, 2022 Category: International Medicine & Public Health Source Type: research
Direct cost of cochlear implants in Germany – a strategic simulation
ConclusionCI demand by adults will increase in the future, thus will the costs for CI supply. Continuous research and development in CI technology and supply is crucial to ensure long-term financing of the growing CI demand through cost-reducing innovations. (Source: Health Economics Review)
Source: Health Economics Review - December 24, 2022 Category: International Medicine & Public Health Source Type: research
Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan
Limited information is available on the utility values of metastatic pancreatic cancer, focusing on different health statuses, selected chemotherapy, and related grades 1/2 and 3/4 adverse events (AEs). We eva... (Source: Health Economics Review)
Source: Health Economics Review - December 24, 2022 Category: Health Management Authors: Takumoto Yuki, Sasahara Yuriko, Narimatsu Hirohito, Murata Tatsunori and Akazawa Manabu Tags: Research Source Type: research
Direct cost of cochlear implants in Germany – a strategic simulation
Despite the current undersupply of cochlear implants (CIs) with simultaneously increasing indication, CI implantation numbers in Germany still are at a relatively low level. (Source: Health Economics Review)
Source: Health Economics Review - December 24, 2022 Category: Health Management Authors: Christin Thum, Thomas Lenarz and Steffen Fle ßa Tags: Research Source Type: research
Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan
ConclusionsWe clarified the health state utility values of patients with metastatic pancreatic cancer based on the general population in Japan. The effect on utilities should be considered not only for serious AEs, but also for minor AEs. (Source: Health Economics Review)
Source: Health Economics Review - December 24, 2022 Category: International Medicine & Public Health Source Type: research
Direct cost of cochlear implants in Germany – a strategic simulation
ConclusionCI demand by adults will increase in the future, thus will the costs for CI supply. Continuous research and development in CI technology and supply is crucial to ensure long-term financing of the growing CI demand through cost-reducing innovations. (Source: Health Economics Review)
Source: Health Economics Review - December 24, 2022 Category: International Medicine & Public Health Source Type: research
